Skip to content
★ Sign in to follow
RP

Rich Pharmaceuticals, Inc. Stock: price and insider trades · United States

Rich Pharmaceuticals, Inc.: what insiders have been doing

We have very little insider data for Rich Pharmaceuticals, Inc. so far: the most recent filing dates from 6 April 2017. With so few records, no pattern can be drawn yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2018

FY ended March 2018 · cache

Income statement
Revenue102.5k
Net income-1.5M-1471.6% margin
Last declaration on 6 April 2017
Declarations3 total
  • ◆
    CEO, CFO, PresExecutives
    0SEC
    3,000,000,000 shares0Common StockSEC:0001662252-17-000080:0
  • ◆
    CEO, CFO, PresExecutives
    0SEC
    220,792,028 shares0Common StockSEC:0001255294-14-001050:0
  • ◆
    CEO, CFO, PresExecutives
    0SEC
    8,000,000 shares0Common StockSEC:0001255294-14-001050:1

3 of 3 declarations

About Rich Pharmaceuticals, Inc.

Rich Pharmaceuticals, Inc. is a company focused on developing treatments for serious diseases. It is listed on the NASDAQ under the symbol RICH.